Evidence map›Paper›PMID 22245795›Full record

ArticleHeart rhythm2012

Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective.

Katja E Odening, Bum-Rak Choi, Gong Xin Liu, Kathryn Hartmann, Ohad Ziv, Leonard Chaves, Lorraine Schofield, Jason Centracchio, Manfred Zehender, Xuwen Peng and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Heart rhythm, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Variable expressivity in long QT syndrome type 2 rabbits defines a low threshold for therapeuticAmerican journal of physiology. Heart and circulatory physiology · 2026
    Article
  3. Review
  4. Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Beneficial action potential duration-shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  12. Article
  13. NaInternational journal of cardiology. Heart & vasculature · 2025
    Article
  14. Article
  15. Postpartum QT Prolongation in a Long QT Syndrome Type 1 Patient.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Katja E OdeningAlpert Medical School of Brown University, Providence, RI, USA.
Bum-Rak Choi
Gong Xin Liu
Kathryn Hartmann
Ohad Ziv
Leonard Chaves
Lorraine Schofield
Jason Centracchio
Manfred Zehender
Xuwen Peng
Michael Brunner
Gideon Koren
Brown University · USRhode Island Hospital · USUniversity Medical Center Freiburg · DEPennsylvania State University · US

Funding

HEART AND MUSCLE K+ CHANNELS--STRUCTURE AND FUNCTIONR01HL046005 · NHLBI · RHODE ISLAND HOSPITAL · PI KOREN, GIDEON · 1991 to 2013
$5.9M
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 RabbitsR01HL093205 · NHLBI · RHODE ISLAND HOSPITAL · PI KOREN, GIDEON · 2009 to 2012
$2.3M
NHLBI NIH HHS HL093205NHLBI NIH HHS R01 HL046005NHLBI NIH HHS R01 HL046005-18NHLBI NIH HHS R01 HL093205
6 · The paper itself

Abstract

backgroundPostpubertal women with inherited long QT syndrome type 2 (LQT2) are at increased risk for polymorphic ventricular tachycardia (pVT) and sudden cardiac death (SCD), particularly during the postpartum period.

objectiveTo investigate whether sex hormones directly modulate the arrhythmogenic risk in LQTS.

methodsPrepubertal ovariectomized transgenic LQT2 rabbits were treated with estradiol (EST), progesterone (PROG), dihydrotestosterone (DHT), or placebo (OVX).

resultsDuring 8 weeks of treatment, major cardiac events-spontaneous pVT or SCD-occurred in 5 of the 7 EST rabbits and in 2 of the 9 OVX rabbits (P <.05); in contrast, no events occurred in 9 PROG rabbits and 6 DHT rabbits (P <.01 vs PROG; P <.05 vs DHT). Moreover, EST increased the incidence of pVT (P <.05 vs OVX), while PROG reduced premature ventricular contractions, bigeminy, couplets, triplets, and pVT (P <.01 vs OVX; P <.001 vs EST). In vivo electrocardiographic monitoring, in vivo electrophysiological studies, and ex vivo optical mapping studies revealed that EST promoted SCD by steepening the QT/RR slope (P <.05), by prolonging cardiac refractoriness (P <.05), and by altering the spatial pattern of action potential duration dispersion. Isoproterenol-induced Ca(2+) oscillations resulted in early afterdepolarizations in EST-treated hearts (4 of 4), while PROG prevented SCD by eliminating this early afterdepolarization formation in 4 of the 7 hearts (P = .058 vs EST; P <.05 vs OVX). Analyses of ion currents demonstrated that EST increased the density of I(Ca,L) as compared with OVX (P <.05) while PROG decreased it (P <.05).

conclusionThis study reveals the proarrhythmic effect of EST and the antiarrhythmic effect of PROG in LQT2 in vivo, outlining a new potential antiarrhythmic therapy for LQTS.

Indexed as

AnimalsAnimals, Genetically ModifiedArrhythmias, CardiacDeath, Sudden, CardiacDihydrotestosteroneEstradiolFemaleLong QT SyndromeProgesteroneRabbitsDihydrotestosteroneEstradiolProgesterone

Identifiers

PMID22245795
PMCPMC4397932
OpenAlexW1988720159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.